Syquant Capital SAS’s Verona Pharma VRNA Stock Holding History

Syquant Capital SAS’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,208,312	Closed	-$129M	–	44
2025 Q3	$129M	Buy	+1,208,312	New	+$126M	37.01%	1

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Syquant Capital SAS's VRNA Position: Q4 2025 in Review

Syquant Capital SAS sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,208,312 shares — an estimated $129M sold.

Syquant Capital SAS first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $129M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Syquant Capital SAS reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Syquant Capital SAS sold 1,208,312 Verona Pharma shares in Q4 2025, an estimated $129M.
Syquant Capital SAS first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Syquant Capital SAS's Verona Pharma position peaked at $129M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Syquant Capital SAS's 13F filing for Q4 2025, filed 13 Jan 2026.